Regulation of SIRT1 by microRNAs

Molecules and Cells

Volumn 36, Issue 5, 2013, Pages 385-392

  Choi, Sung E ^a,b   Kemper, Jongsook Kim ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b Ajou University   (South Korea)

Author keywords

Aging; Deacetylase; NAD; NAMPT; Obesity; Therapeutics

Indexed keywords

MICRORNA; MICRORNA 34A; NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; SIRTUIN; SIRTUIN 1;

CELL ENERGY; HUMAN; METABOLIC DISORDER; OBESITY; PROTEIN EXPRESSION; SHORT SURVEY;

MAMMALIA;

ANIMALS; GENE EXPRESSION REGULATION; HUMANS; MICRORNAS; NAD; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; OBESITY; SIRTUIN 1; SIRTUINS; UP-REGULATION;

EID: 84900423595     PISSN: 10168478     EISSN: 02191032     Source Type: Journal    
DOI: 10.1007/s10059-013-0297-1     Document Type: Short Survey

References (81)

1. Aksoy, P., White, T.A., Thompson, M., and Chini, E.N. (2006). Regulation of intracellular levels of NAD: a novel role for CD38. Biochem. Biophys. Res. Commun. 345, 1386-1392. (Pubitemid 43817885)
2. Bai, P., Canto, C., Oudart, H., Brunyanszki, A., Cen, Y., Thomas, C., Yamamoto, H., Huber, A., Kiss, B., Houtkooper, R.H., et al. (2011). PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation. Cell Metab. 13, 461-468.
3. Barber, M.F., Michishita-Kioi, E., Xi, Y., Tasselli, L., Kioi, M., Moqtaderi, Z., Tennen, R.I., Paredes, S., Young, N.L., Chen, K., et al. (2012). SIRT7 links H3K18 deacetylation to maintenance of oncogenic transformation. Nature 487, 114-118.
4. Baroukh, N., Ravier, M.A., Loder, M.K., Hill, E.V., Bounacer, A., Scharfmann, R., Rutter, G.A., and Van Obberghen, E. (2007). MicroRNA-124a regulates Foxa2 expression and intracellular signaling in pancreatic β-cell lines. J. Biol. Chem. 282, 19575-19588.
5. Belenky, P., Bogan, K.L., and Brenner, C. (2007). NAD+ metabolism in health and disease. Trends Biochem. Sci. 32, 12-19.
6. Bellizzi, D., Rose, G., Cavalcante, P., Covello, G., Dato, S., De Rango, F., Greco, V., Maggiolini, M., Feraco, E., Mari, V., et al. (2005). A novel VNTR enhancer within the SIRT3 gene, a human homologue of SIR2, is associated with survival at oldest ages. Genomics 85, 258-263. (Pubitemid 40164791)
7. Boon, R.A., Iekushi, K., Lechner, S., Seeger, T., Fischer, A., Heydt, S., Kaluza, D., Tréguer, K., Carmona, G., Bonauer, A., et al. (2013). MicroRNA-34a regulates cardiac ageing and function. Nature 495, 107-110.
8. Canto, C., Houtkooper, R.H., Pirinen, E., Youn, D.Y., Oosterveer, M. H., Cen, Y., Fernandez-Marcos, P.J., Yamamoto, H., Andreux, P.A., Cettour-Rose, P., et al. (2012). The NAD(+) precursor nicotinamide ribosideenhances oxidative metabolism and protects against high-fat diet-induced obesity. Cell Metab. 15, 838-847.
9. Cermelli, S., Ruggieri, A., Marrero, J.A., Ioannou, G.N., and Beretta, L. (2011). Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease. PLoS One 6, e23937.
10. Chang, T.C., Wentzel, E.A., Kent, O.A., Ramachandran, K., Mullendore, M., Lee, K.H., and Feldmann, G., (2007). Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol. Cell 26, 745-752. (Pubitemid 46856245)
11. Chau, M.D., Gao, J., Yang, Q., Wu, Z., and Gromada, J. (2010). Fibroblast growth factor 21 regulates energy metabolism by activating the AMPK-SIRT1-PGC-1alpha pathway. Proc. Natl. Acad. Sci. USA 107, 12553-12558.
12. Cheung, O., Puri, P., Eicken, C., Contos, M.J., Mirshahi, F., Maher, J.W., Kellum, J.M., Min, H., Luketic, V.A., and Sanyal, A.J. (2008). Nonalcoholic steatohepatitis is associated with altered hepatic microRNA expression. Hepatology 48, 1810-1820.
13. Choi, S.E., Fu, T., Seok, S., Kim, D.H., Yu, E., Lee, KW., Kang, Y., Li, X., Kemper, B., and Kemper, J.K. (2013). Elevated micro-RNA-34a in obesity reduces NAD+ levels and SIRT1 activity by directly targeting NAMPT. Aging Cell [Epub ahead of print].
14. Dávalos, A., Goedeke, L., Smibert, P., Ramírez, C.M., Warrier, N.P., Andreo, U., Cirera-Salinas, D., Rayner, K., Suresh, U., Pastor Pareja, J.C., et al. (2011). miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling. Proc. Natl. Acad. Sci. USA 108, 9232-9237.
15. Du, J., Zhou, Y., Su, X., Yu, J.J., Khan, S., Jiang, H., Kim, J., Woo, J., Kim, J.H., Choi, B.H., et al. (2011). Sirt5 is a NAD-dependent protein lysine demalonylase and desuccinylase. Science 334, 806-809.
16. Esau, C., Davis, S., Murray, S.F., Yu, X.X., Pandey, S.K., Pear, M., Watts, L., Booten, S.L., Graham, M., McKay, R., et al. (2006). miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab. 3, 87-98.
17. Finkel, T., Deng, C.X., and Mostoslavsky, R. (2009). Recent progress in the biology and physiology of sirtuins. Nature 460, 587-591.
18. Ford, E., Voit, R., Liszt, G., Magin, C., Grummt, I., and Guarente, L. (2006). Mammalian Sir2 homolog SIRT7 is an activator of RNA polymerase I transcription. Genes Dev. 20, 1075-1080.
19. Fu, T., Choi, S.E., Kim, D.H., Seok, S., Suino-Powell, K.M., Xu, H.E., and Kemper, J.K. (2012). Aberrantly elevated microRNA-34a in obesity attenuates hepatic responses to FGF19 by targeting a membrane coreceptor beta-Klotho. Proc. Natl. Acad. Sci. USA 109, 16137-16142.
20. Guarente, L. (2006). Sirtuins as potential targets for metabolic syndrome. Nature 444, 868-874.
21. Guarente, L. (2011). Sirtuins, aging, and metabolism. Cold Spring Harb. Symp. Quant. Biol. 76, 81-90.
22. Gurd, B.J., Holloway, G.P., Yoshida, Y., and Bonen, A. (2012). In mammalian muscle, SIRT3 is present in mitochondria and not in the nucleus; and SIRT3 is upregulated by chronic muscle contraction in an adenosine monophosphate-activated protein kinase-independent manner. Metabolism 61, 733-741.
23. Haigis, M.C., and Sinclair, D.A. (2010). Mammalian sirtuins: biological insights and disease relevance. Annu. Rev. Pathol. 5, 253-295.
24. He, L., He, X., Lim, L.P., de Stanchina, E., Xuan, Z., Liang, Y., Xue, W., Zender, L., Magnus, J., Ridzon, D., et al. (2007). A micro-RNA component of the p53 tumour suppressor network. Nature 447, 1130-1134. (Pubitemid 47014436)
25. Hobert, O. (2008). Gene regulation by transcription factors and microRNAs. Science 319, 1785-1786.
26. +: an old metabolite controlling new metabolic signaling pathways. Endocr. Rev. 31, 194-223.
27. Houtkooper, R.H., Pirinen, E., and Auwerx, J. (2012). Sirtuins as regulators of metabolism and healthspan. Nat. Rev. Mol. Cell Biol. 13, 225-238.
28. Imai, S., and Kiess, W. (2009). Therapeutic potential of SIRT1 and NAMPT-mediated NAD biosynthesis in type 2 diabetes. Front Biosci. 14, 2983-95.
29. Imai, S., Armstrong, C.M., Kaeberlein, M., and Guarente, L. (2000). Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature 403, 795-800. (Pubitemid 30111843)
30. Iwahara, T., Bonasio, R., Narendra, V., and Reinberg, D. (2012). SIRT3 functions in the nucleus in the control of stress-related gene expression. Mol. Cell. Biol. 32, 5022-5034.
31. Ito, T., Yagi, S., and Yamakuchi, M. (2010). MicroRNA-34a regulation of endothelial senescence. Biochem. Biophys. Res. Commun. 398, 735-740.
32. Kemper, J.K., Xiao, Z., Ponugoti, B., Miao, J., Fang, S., Kanamaluru, D., Tsang, S., Wu, S., Chiang, C.M., and Veenstra, T.D. (2009). FXR acetylation is normally dynamically regulated by p300 and SIRT1 but constitutively elevated in metabolic disease states. Cell Metab. 10, 392-404.
33. Kemper, J.K., Choi, S.E., and Kim, D.H. (2013). Sirtuin 1 deacetylase: a key regulator of hepatic lipid metabolism. Vitam. Horm. 91, 385-404.
34. Khanna, A., Muthusamy, S., Liang, R., Sarojini, H., and Wang, E. (2011). Gain of survival signaling by downregulation of three key miRNAs in brain of calorie-restricted mice. Aging 3, 223-236.
35. Kim, J.K., Noh, J.H., Jung, K.H., Eun, J.W., Bae, H.J., Kim, M.G., Chang, Y.G., Shen, Q., Park, W.S., Lee, J.Y., et al. (2013). Sirtuin7 oncogenic potential in human hepatocellular carcinoma and its regulation by the tumor suppressors MiR-125a-5p and MiR-125b. Hepatology 57, 1055-1067.
36. Kitamura, Y.I., Kitamura, T., Kruse, J.P., Raum, J.C., Stein, R., Gu, W., and Accili, D. (2005). FoxO1 protects against pancreatic beta cell failure through NeuroD and MafA induction. Cell Metab. 2, 153-163.
37. Kong, X., Wang, R., Xue, Y., Liu, X., Zhang, H., Chen, Y., Fang, F., and Chang, Y. (2010). Sirtuin 3, a new target of PGC-1α, plays an important role in the suppression of ROS and mitochondrial biogenesis. PLoS One 5, e11707.
38. Kota, J., Chivukula, R.R., O'Donnell, K.A., Wentzel, E.A., Montgomery, C.L., Hwang, H.W., Chang, T.C., Vivekanandan, P., Torbenson, M., Clark, K.R., et al. (2009). Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell 137, 1005-1017.
39. Lee, J., and Kemper, J.K. (2010). Controlling SIRT1 expression by microRNAs in health and metabolic disease. Aging 2, 527-534.
40. Lee, J., Padhye, A., Sharma, A., Song, G., Miao, J., Mo, Y.Y., Wang, L., and Kemper, J.K. (2010). A pathway involving farnesoid X receptor and small heterodimer partner positively regulates hepatic sirtuin 1 levels via microRNA-34a inhibition. J. Biol. Chem. 285, 12604-126011.
41. Leung, A.K., Vyas, S., Rood, J.E., Bhutkar, A., Sharp, P.A., and Chang, P. (2011). Poly(ADP-Ribose) regulates stress responses and microRNA activity in the cytoplasm. Mol. Cell 42, 489-499.
42. Lewis, B.P., Shih, I.H., Jones-Rhoades, M.W., Bartel, D.P., and Burge, C.B. (2003) Prediction of mammalian microRNA targets. Cell 115, 787-798. (Pubitemid 38058492)
43. Li, S., Chen, X., Zhang, H., Liang, X., Xiang, Y., Yu, C., Zen, K., Li, Y., and Zhang, C.Y. (2009). Differential expression of micro-RNAs in mouse liver under aberrant energy metabolic status. J. Lipid Res. 50, 1756-1765.
44. Li, N., Muthusamy, S., Liang, R., Sarojini, H., and Wang, E. (2011). Increased expression of miR-34a and miR-93 in rat liver during aging, and their impact on the expression of Mgst1 and Sirt1. Mech. Ageing Dev. 132, 75-85.
45. Liu, C., Kelnar, K., Liu, B., Chen, X., Calhoun-Davis, T., Li, H., Patrawala, L., Yan, H., Jeter, C., Honorio, S., et al. (2011). The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Nat. Med. 17, 211-215.
46. Liu, N., Landreh, M., Cao, K., Abe, M., Hendriks, G.J., Kennerdell, J.R., Zhu, Y., Wang, L.S., and Bonini, N.M. (2012). The micro-RNA miR-34 modulates ageing and neurodegeneration in Drosophila. Nature 482, 519-523.
47. Lovis, P., Roggli, E., Laybutt, D.R., Gattesco, S., Yang, J.Y., Widmann, C., Abderrahmani, A., and Regazzi, R. (2008). Alterations in microRNA expression contribute tofatty acid-induced pancreatic beta-cell dysfunction. Diabetes 57, 2728-2736.
48. Menghini, R., Casagrande, V., Cardellini, M., Martelli, E., Terrinoni, A., Amati, F., Vasa-Nicotera, M., Ippoliti, A., Novelli, G., Melino, G., et al. (2009). MicroRNA 217 modulates endothelial cell senescence via silent information regulator 1. Circulation 120, 1524-1532.
49. Mostoslavsky, R., Chua, K.F., Lombard, D.B., Pang, W.W., Fischer, M.R., Gellon, L., Liu, P., Mostoslavsky, G., Franco, S., Murphy, M.M., et al. (2006). Genomic instability and aging-like phenotype in the absence of mammalian SIRT6. Cell 124, 315-329. (Pubitemid 43121980)
50. Najafi-Shoushtari, S.H., Kristo, F., Li, Y., Shioda, T., Cohen, D.E., Gerszten, R.E., and Naar, A.M. (2010). MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis. Science 328, 1566-1569.
51. Nakagawa, T., Lomb, D.J., Haigis, M.C., and Guarente, L. (2009). SIRT5 Deacetylates carbamoyl phosphate synthetase 1 and regulates the urea cycle. Cell 137, 560-570.
52. Nakahata, Y., Sahar, S., Astarita, G., Kaluzova, M., and Sassone-Corsi, P. (2009). Circadian control of the NAD+ salvage pathway by CLOCK-SIRT1. Science 324, 654-657.
53. Neilson, J.R., and Sharp, P.A. (2008). Small RNA regulators of gene expression. Cell 134, 899-902.
54. Ortega, F.J., Moreno-Navarrete, J.M., Pardo, G., Sabater, M., Hummel, M., Ferrer, A., Rodriguez-Hermosa, J.I., Ruiz, B., Ricart, W., Peral, B., et al. (2010). MiRNA expression profi le of human subcutaneous adipose and during adipocyte differentiation. PLoS One 5, e9022.
55. Pillai, J.B., Isbatan, A., Imai, S., and Gupta, M.P. (2005). Poly(ADP-ribose) polymerase-1-dependent cardiac myocyte cell death during heart failure is mediated by NAD+ depletion and reduced Sir2alpha deacetylase activity. J. Biol. Chem. 280, 43121-43130. (Pubitemid 43049278)
56. Pirinen, E., Lo, Sasso, G., and Auwerx, J. (2012). Mitochondrial sirtuins and metabolic homeostasis. Best Pract. Res. Clin. Endocrinol. Metab. 26, 759-770.
57. Ponugoti, B., Kim, D.H., Xiao, Z., Smith, Z., Miao, J., Zang, M., Wu, S.Y., Chiang, C.M., Veenstra, T.D., and Kemper, J.K. (2010), SIRT1 deacetylates and inhibits SREBP-1C activity in regulation of hepatic lipid metabolism. J. Biol. Chem. 285, 33959-33970.
58. Pramanik, D., Campbell, N.R., Karikari, C., Chivukula, R., Kent, O. A., Mendell, J.T., and Maitra, A. (2011). Restitution of tumor suppressor microRNAs using a systemic nanovector inhibits pancreatic cancer growth in mice. Mol. Cancer Ther. 10, 1470-1480.
59. Qiang, L., Wang, L., Kon, N., Zhao, W., Lee, S., Zhang, Y., Rosenbaum, M., Zhao, Y., Gu, W., Farmer, S.R., et al. (2012). Brown remodeling of white adipose tissue by SirT1-dependent deacetylation of Pparaγ. Cell 150, 620-632.
60. Ramachandran, D., Roy, U., Garg, S., Ghosh, S., Pathak, S., and Kolthur-Seetharam, U. (2011). Sirt1 and mir-9 expression is regulated during glucose-stimulated insulin secretion in pancreatic β-islets. FEBS J. 278, 1167-1174.
61. Ramsey, K.M., Yoshino, J., Brace, C.S., Abrassart, D., Kobayashi, Y., Marcheva, B., Hong, H.K., Chong, J.L., Buhr, E.D., Lee, C., et al. (2009). Circadian clock feedback cycle through NAMPT-mediated NAD+ biosynthesis. Science 324, 651-654.
62. Rayner, K.J., Suarez, Y., Davalos, A., Parathath, S., Fitzgerald, M.L., Tamehiro, N, Fisher, E.A., Moore, K.J., and Fernandez-Hernando, C. (2010). MiR-33 contributes to the regulation of cholesterol homeostasis. Science 328, 1570-1573.
63. Rodgers, J.T., and Puigserver, P. (2007). Fasting-dependent glucose and lipid metabolic response through hepatic sirtuin 1. Proc. Natl. Acad. Sci. USA 104, 12861-12866. (Pubitemid 47255245)
64. Rodgers, J.T., Lerin, C., Haas, W., Gygi, S.P., Spiegelman, B.M., and Puigserver, P. (2005). Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nature 434, 113-118. (Pubitemid 40349395)
65. Rottiers, V., Najafi-Shoushtari, S.H., Kristo, F., Gurumurthy, S., Zhong, L., Li, Y., Cohen, D.E., Gerszten, R.E., Bardeesy, N., Mostoslavsky, R., et al. (2011). MicroRNAs in metabolism and metabolic diseases. Cold Spring Harb. Symp. Quant. Biol. 76, 225-233.
66. Rose, G., Dato, S., Altomare, K., Bellizzi, D., Garasto, S., Greco, V., Passarino, G., Feraco, E., Mari, V., Barbi, C., et al. (2003). Variability of the SIRT3 gene, human silent information regulator Sir2 homologue, and survivorship in the elderly. Exp. Gerontol. 38, 1065-1070. (Pubitemid 37324417)
67. Sharma, A., Diecke, S., Zhang, W.Y., Lan, F., He, C., Mordwinkin, N.M., Chua, K.F., and Wu, J.C. (2013). The role of SIRT6 protein in aging and reprogramming of human induced pluripotent stem cells. J. Biol. Chem. 288, 18439-18447.
68. Strum, J.C., Johnson, J.H., Ward, J., Xie, H., Field, J., Hester, A., Alford, A., and Waters, K.M. (2009). MicroRNA 132 regulates nutritional stressinduced chemokine production through repression of SirT1. Mol. Endocrinol. 23, 1876-1884.
69. Trajkovski, M., Hausser, J., Soutschek, J., Bhat, B., Akin, A., Zavolan, M., Heim, M.H., and Stoffel, M. (2011). MicroRNAs 103 and 107 regulate insulin sensitivity. Nature 474, 649-653.
70. Vakhrusheva, O., Smolka, C., Gajawada, P., Kostin, S., Boettger, T., Kubin, T., Braun, T., and Bober, E. (2008). Sirt7 increases stress resistance of cardiomyocytes and prevents apoptosis and inflammatory cardiomyopathy in mice. Circ. Res. 102, 703-710. (Pubitemid 351457857)
71. Van Rooji, E. (2011). The art of microRNA research. Circ. Res. 108, 219-234.
72. Walker, A.K., Yang, F., Jiang, K., Ji, J.Y., Watts, J.L., Purushotham, A., Boss, O., Hirsch, M.L., Ribich, S., Smith, J.J., et al. (2010). Conserved role of SIRT1 orthologs in fasting-dependent inhibition of the lipid/cholesterol regulator SREBP. Genes Dev. 24, 1403-1417.
73. Xie, H., Lim, B., and Lodish, H.F. (2009). MicroRNAs induced during adipogenesis that accelerate fat cell development are downregulated in obesity. Diabetes 58, 1050-1057.
74. Yamakuchi, M., Ferlito, M., and Lowenstein, C.J. (2008). miR-34a repression of SIRT1 regulates apoptosis. Proc. Natl. Acad. Sci. USA 105, 13421-13426.
75. Yamamoto, H., Schoonjans, K., and Auwerx, J. (2007). Sirtuin functions in health and disease Mol. Endocrinol. 21, 1745-1755. (Pubitemid 47173788)
76. Yang, J.S., and Lai, E.C. (2011). Alternative miRNA biogenesis pathways and the interpretation of core miRNA pathway mutants. Mol. Cell 43, 892-903.
77. Yoshino, J., Mills, K.F., Yoon, M.J., and Imai, S. (2011). Nicotinamide mononucleotide, a key NAD(+) intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice. Cell Metab. 14, 528-536.
78. Yoshizaki, T., Milne, J.C., Imamura, T., Schenk, S., Sonoda, N., Babendure, J.L., Lu, J.C., Smith, J.J., Jirousek, M.R., and Olefsky, J.M. (2009). sirT1 exerts anti-inflammatory effects and improves insulin sensitivity in adipocytes. Mol. Cell. Biol. 29, 1363-1374.
79. Zhang, C., Tong, J., and Huang, G. (2013). Nicotinamide phosphoribosyl transferase (Nampt) is a target of MicroRNA-26b in colorectal cancer cells. PLoS One 8, e69963.
80. Zhou, B., Li, C., Qi, W., Zhang, Y., Zhang, F., Wu, J.X., Hu, Y.N., Wu, D.M., Liu, Y., Yan, T.T., et al. (2012). Downregulation of miR-181a upregulates sirtuin-1 (SIRT1) and improves hepatic insulin sensitivity. Diabetologia 55, 2032-2043.
81. Zovoilis, A., Agbemenyah, H.Y., Agis-Balboa, R.C., Stilling, R.M., Edbauer, D., Rao, P., Farinelli, L., Delalle, I., Schmitt, A., Falkai, P., et al. (2011). microRNA-34c is a novel target to treat dementias. EMBO J. 30, 4299-4308.